Interleukin-12 augments cytolytic activity of peripheral and decidual lymphocytes against choriocarcinoma cell lines and primary culture human placental trophoblasts

Am J Reprod Immunol. 1999 May;41(5):320-9. doi: 10.1111/j.1600-0897.1999.tb00445.x.

Abstract

Problem: Human trophoblasts are tolerant to the maternal immune system, but susceptible to interleukin (IL)-2-activated lymphocytes. IL-12 is also a key cytokine in the induction of cytotoxic responses. We administered IL-12 to peripheral blood lymphocytes (PBLs) and to decidual lymphocytes (DLs) and studied resulting cytotoxicity against trophoblasts.

Method of study: PBLs and DLs were stimulated with rIL-2 and/or rIL-12 for 48 hr in vitro. Cytotoxicity against the choriocarcinoma cell line JEG-3, JAR, and primary culture trophoblasts were examined by LDH release assay. The proliferative response was estimated by MTT assay. Expression of cytotoxic factors was studied by reverse transcriptase-polymerase chain reaction (RT-PCR).

Results: Whereas IL-12 alone produced a modest enhancement in cytotoxicity of PBLs and DLs, the combination of IL-2 and IL-12 was most effective in trophoblast cell lysis. IL-12 enhanced the mRNA expression of T-cell specific serine protease (TSP, granzyme B) and FasL in DLs, but the expression of perforin was unchanged. Expression of these cytotoxic factors in PBLs was up-regulated by IL-12.

Conclusion: Our findings indicate critical roles of IL-12 in the activation of maternal lymphocytes, which could possibly result in pregnancy failure syndromes.

MeSH terms

  • Adult
  • Choriocarcinoma / immunology*
  • Cytotoxicity, Immunologic / drug effects*
  • Decidua / immunology*
  • Female
  • Humans
  • Interleukin-12 / pharmacology*
  • Male
  • Pregnancy
  • T-Lymphocytes / immunology*
  • Trophoblasts / immunology*
  • Tumor Cells, Cultured
  • Uterine Neoplasms / immunology*

Substances

  • Interleukin-12